PUBLISHER: DataM Intelligence | PRODUCT CODE: 1542936
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1542936
Report Overview
Global Osseointegration Implants Market reached US$ 5.21 million in 2023 and is expected to reach US$ 15.20 million by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031
Osseointegration implants are medical devices that create a direct connection between living bone and an artificial implant's surface, ensuring stability and durability. Initially developed for dental applications, they have since expanded to orthopedics and prosthetics, securing joint replacements and limb prostheses. This technology has revolutionized implant integration, improving comfort, functionality, and long-term success, leading to improved outcomes in various fields.
Market Dynamics: Drivers & Restraints
Rise in advancements of devices
Osseointegration can be improved by surface modification on the micro and nanoscale. Bioactive agents can further improve the osseointegration potential. Used agents at the moment are e.g. inorganic compounds, growth factors (BMPs and non-BMPs), and antiresorptive drugs. The advancement in research on new implant generations therefore aims at actively supporting osseointegration processing.
Moreover, the TSIII SOI implant is a groundbreaking advancement in the field of dental implantology, boasting unprecedented blood coagulation capability and excellent osseointegration characteristics. These recent achievements in biocompatibility improve the entire patient experience and support aesthetic and functional restoration.
High cost associated with implants
The osseointegration implants market faces challenges such as high costs, surgical procedures, complexity of surgery, specialized training, regulatory hurdles, and concerns about long-term success and potential complications. These factors make them less accessible to patients in low- and middle-income regions and hinder the widespread adoption of these techniques.
Additionally, regulatory hurdles and lengthy approval processes can delay market entry for innovative products. These factors can affect patient and clinician confidence in adopting advanced solutions.
Market Segment Analysis
The global osseointegration implants market is segmented based on product type, material type, end-user, and region.
The dental implants from the product type segment accounted for approximately 41.3% of the osseointegration implants market share
The dental implants from the product type segment accounted for approximately 41.3%. Dental implants are vital for osseointegration, a process where the implant acts as an artificial tooth root. Over time, the surrounding bone tissue grows and integrates with the implant's surface, forming a stable connection. This osseointegration allows the implant to be firmly anchored, providing a solid foundation for dental crowns, bridges, or dentures. The strength of this bond ensures the implant can withstand chewing forces and maintain bone integrity, preventing bone resorption after tooth loss.
For instance, in February 2024, ZimVie Inc a global life sciences leader in the dental and spine markets, announced the launch of the TSX Implant in Japan. As ZimVie's largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.
Market Geographical Share
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, and expansion with other companies. Also, growth can be attributed to developed healthcare infrastructure, greater expenditure on healthcare, and higher awareness about minimally invasive surgeries.
For instance, in March 2023, WVU Medicine became one of the first medical centers in the country to offer the Integrum Osseo anchored Prostheses for the Rehabilitation of Amputees (OPRA(TM)) Implant System for the treatment of lower extremity amputations.
Moreover, in July 2023, Parkview Regional Medical Center and Orthopedics North East launched an osseointegration program in Indiana, utilizing Integrum's OPRA Implant System. This innovative program, the first of its kind in the state, uses advanced bone-anchored prosthesis technology to improve the quality of life for individuals with lower extremity amputations.
Market Competitive Landscape
The major global players in the market include Danaher Corporation, Camlog, Osstem Implant, Medtronic, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc, Straumann AG Group, Integrum SE, and ConMed Corporation among others.
The global osseointegration implants market report would provide approximately 64 tables, 61 figures, and 186 pages.
Target Audience 2024
¬¬¬¬